What one share of Madrigal Pharmaceuticals holds
We are a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (“MASH”), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality.
Madrigal Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $56.08 |
|---|---|
| Profit | −$14.20 |
| Capex (buildings and equipment) | $0.37 |
| Free cash flow | −$9.01 |
| Cash and investments | $12.68 |
| Debt | $14.76 |
| Book value | $22.68 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2015 | — | −$40.03 | $0.34 | −$18.71 | — | −$277.67 |
| 2016 | — | −$5.07 | $0.00 | −$3.38 | — | — |
| 2017 | $0.00 | −$2.54 | $0.01 | −$1.83 | — | $12.81 |
| 2018 | $0.00 | −$2.22 | $0.00 | −$1.73 | — | $30.95 |
| 2019 | $0.00 | −$5.45 | $0.01 | −$2.71 | — | $27.00 |
| 2020 | $0.00 | −$13.09 | $0.02 | −$10.22 | — | $15.47 |
| 2021 | $0.00 | −$14.63 | $0.01 | −$11.14 | — | $11.47 |
| 2022 | $0.00 | −$17.23 | $0.01 | −$13.13 | — | $10.90 |
| 2023 | $0.00 | −$19.99 | $0.08 | −$17.43 | — | $20.39 |
| 2024 | $8.47 | −$21.90 | $0.07 | −$21.48 | — | $34.28 |
| 2025 | $42.72 | −$12.85 | $0.02 | −$8.47 | — | $26.39 |
Common questions about Madrigal Pharmaceuticals
How much does one share of Madrigal Pharmaceuticals earn?
Over the last 12 months, Madrigal Pharmaceuticals lost $14.20 for each share on $56.08 of sales.
Does Madrigal Pharmaceuticals pay a dividend?
Madrigal Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Madrigal Pharmaceuticals’s book value per share?
Madrigal Pharmaceuticals’s book value is $22.68 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Madrigal Pharmaceuticals have?
Each share of Madrigal Pharmaceuticals has $12.68 of cash and investments and $14.76 of debt, as of June 30, 2026.
What is Madrigal Pharmaceuticals’s free cash flow per share?
−$9.01 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Madrigal Pharmaceuticals bought back shares?
Madrigal Pharmaceuticals’s share count rose about 13019% from 2015 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.